Susman shared Tuesday that she’ll be stepping down from her role as EVP and chief corporate affairs officer after 18 years with the company. Susman joined Pfizer in 2007 and helped lead the company ...

One of the best known communications executives in corporate America, Susman worked at Pfizer for nearly two decades after ...

They’re lending to businesses owed money that’s in effect guaranteed by the mighty US government. Pfizer’s corporate affairs chief Sally Susman is leaving after 18 years at the pharmaceutical company.

Investing.com -- 据彭博社报道，辉瑞制药公司 (Pfizer Inc.)正在进行企业重组，包括公司首席企业事务官Sally Susman的离职，她已经管理公共传播工作近二十年。 根据彭博社报道，引用首席执行官Albert ...

According to Bloomberg, citing an email sent by Chief Executive Officer Albert Bourla on Tuesday, Susman’s responsibilities ...

Pfizer (PFE) stock in focus as Sally Susman, the company's Chief Corporate Affairs Officer, plans to depart after 18 years.

Pfizer chief corporate affairs officer Sally Susman is departing the company after roughly two decades, CEO Albert Bourla ...

NEW YORK - Sally Susman, Pfizer's executive VP and chief corporate affairs officer, will depart the pharmaceutical giant at ...

The lawmakers accuse Pfizer, Merck, J&J, AbbVie and Amgen of paying little to nothing in federal taxes despite generating billions of dollars annually.

Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trump's plan By Annika Kim Constantino, CNBC • Published June 17, 2025 • Updated on June 17, 2025 at 10 ...

Pfizer's CEO discussed the extensive due diligence the company has conducted on the 3SBio PD-1xVEGF deal. Otsuka detailed its phase 3 data in the kidney disease immunoglobulin A nephropathy (IgAN).